The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3)	Alzheimer disease, Arterial Occlusive Diseases, Cerebral Small Vessel Diseases, Charcot-Marie-Tooth disease type 1F, Cognition Disorders, Cognitive Dysfunction, Frontotemporal Lobar Degeneration, Leukoencephalopathies, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Pick disease, Signs and Symptoms, aphasia, arteriosclerosis disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, communication disorder, dementia, frontotemporal dementia, intracranial arterial disease, intracranial arteriosclerosis, language disorder, nervous system disorder, neurodegenerative disease, psychiatric disorder, speech disorder, stroke disorder, tauopathy, vascular dementia, vascular disorder	Recruiting	Not stated	2023-06-01		NCT05885295

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Imperial College London	220

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Imperial College London	London	United Kingdom	4